BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Refractec, Inc. 

5 Jenner, Suite 150

Irvine  California  92618  U.S.A.
Phone: 949-784-2600-or-800-752-9544 Fax: 949-784-2601


SEARCH JOBS


Industry
Medical Device

Segment
Start Up





 Company News
Renowned Ophthalmologist Richard L. Lindstrom Joins Refractec, Inc. Board Of Directors 10/17/2006 11:01:45 AM    More...
Refractec, Inc. Promotes Thomas G. Frinzi To Chief Executive Officer 6/8/2006 10:49:58 AM    More...
Refractec, Inc. Promotes Thomas G. Frinzi To Chief Executive Officer 6/7/2006 2:28:38 PM    More...
Refractec, Inc. And Eyemaginations, Inc. To Collaborate On 3D Presbyopia Patient Education Program 1/9/2006 11:58:06 AM    More...
Refractec, Inc. Promotes Thomas G. Frinzi To Chief Operating Officer 10/19/2005 5:13:17 PM    More...
Refractec, Inc. Release: FDA Approves First And Only Vision Technology For Presbyopic Baby Boomers: The Viewpoint CK System For NearVision CK (Conductive Keratoplasty) 10/19/2005 5:10:31 PM    More...
FDA Panel Recommends Approval Of Refractec, Inc.'s CK System For Presbyopic Patients Who Need Near Vision Improvement 10/19/2005 5:09:57 PM    More...

//-->